3-D Matrix Ltd. (DMTRF)
2.425
0.00 (0.00%)
USD |
OTCM |
Oct 20, 16:00
3-D Matrix Net Income (Quarterly) : 1.888M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 1.888M |
| April 30, 2026 | 11.43M |
| January 31, 2026 | 4.186M |
| October 31, 2025 | 6.284M |
| July 31, 2025 | 5.261M |
| April 30, 2025 | -7.463M |
| January 31, 2025 | -3.803M |
| October 31, 2024 | -0.1254M |
| July 31, 2024 | -5.012M |
| April 30, 2024 | 2.941M |
| January 31, 2024 | -3.822M |
| October 31, 2023 | -1.002M |
| July 31, 2023 | 0.0618M |
| April 30, 2023 | -2.723M |
| January 31, 2023 | -12.52M |
| October 31, 2022 | 1.013M |
| July 31, 2022 | -3.938M |
| April 30, 2022 | 1.463M |
| January 31, 2022 | -7.248M |
| October 31, 2021 | -4.009M |
| July 31, 2021 | -7.258M |
| April 30, 2021 | -4.144M |
| January 31, 2021 | -4.597M |
| October 31, 2020 | -6.433M |
| July 31, 2020 | -3.811M |
| Date | Value |
|---|---|
| April 30, 2020 | -8.829M |
| January 31, 2020 | -6.075M |
| October 31, 2019 | -5.939M |
| July 31, 2019 | -7.706M |
| April 30, 2019 | -5.928M |
| January 31, 2019 | -5.973M |
| October 31, 2018 | -5.403M |
| July 31, 2018 | -5.667M |
| April 30, 2018 | -5.452M |
| January 31, 2018 | -4.504M |
| October 31, 2017 | -3.794M |
| July 31, 2017 | -3.174M |
| April 30, 2017 | -1.154M |
| January 31, 2017 | -2.990M |
| October 31, 2016 | -3.677M |
| July 31, 2016 | -5.171M |
| April 30, 2016 | -4.757M |
| January 31, 2016 | -8.220M |
| October 31, 2015 | -3.950M |
| July 31, 2015 | -3.690M |
| April 30, 2015 | -3.407M |
| January 31, 2015 | -3.719M |
| October 31, 2014 | -4.839M |
| July 31, 2014 | -6.232M |
| April 30, 2014 | -4.563M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Healios KK | 7.474M |
| GNI Group Ltd. | 17.50M |
| AnGes, Inc. | -10.24M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alkermes Plc | 0.501M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 20.10M |
| Total Expenses (Quarterly) | 18.21M |
| EPS Diluted (Quarterly) | 0.0141 |
| Enterprise Value | 303.49M |
| Gross Profit Margin (Quarterly) | 80.07% |
| Profit Margin (Quarterly) | 9.39% |
| Earnings Yield | 7.25% |
| Operating Earnings Yield | 4.39% |